Capitalizator.

Capitalize Yourself: Right Data. Real Growth.

Company Analysis

ALZN Insider Trading

Alzamend Neuro, Inc. | Pharmaceutical Preparations

Comprehensive Trading Performance Summary

The investment history of corporate insiders at Alzamend Neuro, Inc. provides a unique lens into the internal conviction of the company's leadership. By analyzing SEC Form 4 filings, investors can track how directors and officers are allocating their own capital. High-conviction buying often signals that management believes the current market price significantly undervalues future growth prospects, while strategic selling might occur for personal liquidity or portfolio diversification. Monitoring these shifts in ownership is essential for understanding the alignment between management and shareholders in the Pharmaceutical Preparations sector.

Last 7 Days
$0
Buys
$0
Sells
Last 30 Days Trend
$0
Buys
$0
Sells

Transactions on Chart

Open Full Chart
Filing Date Trade Date Reporting Person Relationship Type Price Qty Total, $ Owned After Change, %
2025-12-31 01:54 2025-12-23 AULT MILTON C III Director SELL $2.07 1,851 $3,825 0 -100.0%
2025-12-24 00:30 2025-12-19 Horne William B. Director SELL $2.12 3,333 $7,059 0 -100.0%
2025-10-24 23:30 2025-10-23 McGrath Lynne Fahey Director SELL $2.29 30 $69 25 -54.5%
2025-10-10 23:30 2025-10-08 AULT MILTON C III Director SELL $2.42 121,791 $294,552 8,260 -93.6%
2025-10-08 13:50 2025-10-06 AULT MILTON C III Director SELL $2.47 139,412 $344,222 68,848 -66.9%
2025-10-04 04:35 2025-10-01 AULT MILTON C III Director SELL $2.41 123,366 $296,794 8,260 -93.7%
2025-10-01 02:15 2025-09-26 AULT MILTON C III Director, 10% owner SELL $2.31 79,628 $184,156 31,626 -71.6%
2025-09-26 03:59 2025-09-23 AULT MILTON C III Director, 10% owner SELL $2.34 97,006 $226,926 11,254 -89.6%
2025-09-23 23:30 2025-09-19 AULT MILTON C III Director, 10% owner SELL $2.35 77,009 $180,856 8,260 -90.3%
2025-09-19 23:50 2025-09-17 AULT MILTON C III Director, 10% owner SELL $2.47 22,991 $56,696 85,269 -21.2%
2025-08-01 23:30 2025-07-30 AULT MILTON C III Director, 10% owner SELL $2.28 129,449 $295,532 8,260 -94.0%
2025-07-29 23:55 2025-07-25 AULT MILTON C III Director, 10% owner SELL $2.86 44,843 $128,170 37,709 -54.3%
2025-07-26 03:00 2025-07-23 AULT MILTON C III Director, 10% owner SELL $2.95 69,137 $203,823 82,552 -45.6%
2025-05-15 00:00 2025-05-12 AULT MILTON C III Director, 10% owner SELL $5.06 1,224 $6,196 1,843 -39.9%
2025-03-27 14:30 2025-03-26 Horne William B. Director BUY $0.99 3,334 $3,285 30,000 +12.5%
2025-03-25 23:30 2025-03-21 AULT MILTON C III Director, 10% owner BUY $1.02 2,905 $2,969 85,273 +3.5%
2025-03-24 14:30 2025-03-21 Katzoff David J Officer - Chief Financial Officer BUY $1.01 5,000 $5,048 5,540 +925.9%
2025-03-20 23:30 2025-03-20 Horne William B. Director BUY $0.98 5,000 $4,892 26,666 +23.1%
2025-03-19 23:30 2025-03-18 Horne William B. Director BUY $0.97 5,000 $4,852 21,666 +30.0%
2025-03-19 02:12 2025-03-18 AULT MILTON C III Director, 10% owner BUY $0.96 5,000 $4,810 82,368 +6.5%
2025-03-15 00:30 2025-03-12 AULT MILTON C III Director, 10% owner BUY $0.68 100 $68 77,368 +0.1%
2024-08-15 01:01 2024-08-06 AULT MILTON C III Director, 10% owner BUY $2.75 75 $206 77,268 +0.1%
2024-08-02 00:20 2024-07-31 AULT MILTON C III Director, 10% owner BUY $3.74 25 $93 77,193 +0.0%
2024-04-24 03:00 2024-04-19 AULT MILTON C III Director, 10% owner BUY $0.69 1,000 $688 771,699 +0.1%
2024-04-04 00:00 2024-04-01 AULT MILTON C III Director, 10% owner BUY $0.91 334 $304 770,699 +0.0%
2024-04-01 23:30 2024-01-05 AULT MILTON C III Director, 10% owner BUY $1.06 2,000 $2,127 770,365 +0.3%
2024-01-10 00:30 2024-01-05 AULT MILTON C III Director, 10% owner BUY $1.02 5,000 $5,093 768,365 +0.7%
2023-12-28 00:30 2023-12-22 AULT MILTON C III 10% owner BUY $0.91 700 $635 26,032 +2.8%
2023-09-27 01:01 2023-09-26 Katzoff David J Officer - Chief Financial Officer BUY $0.19 53,000 $10,234 81,000 +189.3%
2023-05-27 04:30 2023-05-24 AULT MILTON C III 10% owner BUY $0.59 18,000 $10,705 383,000 +4.9%
2023-05-02 23:30 2023-04-28 Jackman Stephan Director, Officer - Chief Executive Officer BUY $0.54 37,000 $19,999 45,500 +435.3%
2023-03-23 23:30 2023-03-22 McGrath Lynne Fahey Director BUY $0.44 10,000 $4,350 10,000 +100.0%
2023-03-20 23:30 2023-03-16 AULT MILTON C III 10% owner BUY $0.46 9,000 $4,154 11,060,001 +0.1%
2023-02-18 05:55 2023-02-15 AULT MILTON C III 10% owner BUY $0.60 1,000 $597 11,051,001 +0.0%
2022-12-29 14:00 2022-12-27 AULT MILTON C III 10% owner BUY $0.57 4,000 $2,277 11,050,001 +0.0%
2022-12-24 00:30 2022-12-21 AULT MILTON C III 10% owner BUY $0.81 5,000 $4,050 11,046,001 +0.0%
2022-12-21 00:30 2022-12-16 AULT MILTON C III 10% owner BUY $0.86 43,000 $36,774 11,041,001 +0.4%
2022-11-22 00:30 2022-11-18 AULT MILTON C III 10% owner BUY $1.29 1,000 $1,289 11,038,001 +0.0%
2022-11-03 23:30 2022-11-02 AULT MILTON C III 10% owner BUY $1.13 1,000 $1,130 10,103,667 +0.0%
2022-11-01 23:30 2022-10-31 AULT MILTON C III 10% owner BUY $1.19 6,000 $7,136 10,102,667 +0.1%
2022-10-14 23:30 2022-10-12 AULT MILTON C III 10% owner BUY $1.23 2,000 $2,467 10,096,667 +0.0%
2022-10-07 23:30 2022-10-06 AULT MILTON C III 10% owner BUY $1.43 1,000 $1,429 10,094,667 +0.0%
2022-09-30 23:30 2022-09-29 AULT MILTON C III 10% owner BUY $1.19 3,500 $4,153 10,093,667 +0.0%
2022-09-20 23:30 2022-09-19 Jackman Stephan Director, Officer - Chief Executive Officer BUY $1.23 8,500 $10,414 8,500 +100.0%
2022-09-15 00:07 2022-09-14 Katzoff David J Officer - Chief Financial Officer BUY $1.11 10,000 $11,092 28,000 +55.6%
2022-08-29 23:30 2022-08-26 AULT MILTON C III 10% owner BUY $0.94 9,100 $8,561 10,016,667 +0.1%
2022-08-26 23:30 2022-08-25 AULT MILTON C III 10% owner BUY $0.96 4,900 $4,704 10,007,567 +0.0%
2022-08-23 23:30 2022-08-22 AULT MILTON C III 10% owner BUY $0.97 36,000 $34,895 10,002,667 +0.4%
2022-08-18 23:30 2022-08-16 AULT MILTON C III 10% owner BUY $1.08 15,000 $16,214 9,966,667 +0.2%
2022-08-16 23:52 2022-08-15 AULT MILTON C III 10% owner BUY $1.06 14,000 $14,833 9,951,667 +0.1%
SHOW ENTRIES
1-50 OF 107

How to Interpret $ALZN Trades

Not every insider transaction in Alzamend Neuro, Inc. is a signal for immediate action. Professional investors look for "cluster buying"—when multiple executives simultaneously purchase $ALZN shares on the open market. It is crucial to distinguish between scheduled sales (under Rule 10b5-1) and voluntary increases in ownership, which demonstrate management’s true conviction that the stock is undervalued.

Data Source & Accuracy for ALZN

Insider activity data for Alzamend Neuro, Inc. is streamed in real-time directly from the SEC EDGAR system. We analyze raw Form 4 filings, filtering out technical adjustments and complex derivative transactions. This provides a transparent view of how ownership structure is evolving in $ALZN, allowing you to follow the capital of those with the most intimate knowledge of the company.

UNDERSTANDING THE DATA

FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.

TRADE DATE: The actual day the insider executed the purchase or sale in the market.

INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.

OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.

CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.

TRADE TYPES DEFINITIONS

BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.

SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.

OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.